MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

Search

Quidel Corp

Closed

27.31 4.8

Overview

Share price change

24h

Current

Min

25.96

Max

27.31

Key metrics

By Trading Economics

Employees

6,600

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+50.94% upside

Dividends

By Dow Jones

Next Earnings

6 lis 2025

Market Stats

By TradingEconomics

Market Cap

127M

1.5B

Previous open

22.51

Previous close

27.31

Quidel Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

15 paź 2025, 23:25 UTC

Major Market Movers

Salesforce Rises on New FY30 Financial Targets

15 paź 2025, 18:52 UTC

Earnings
Major Market Movers

Prologis Shares Gain on Raised Outlook, Data Center Growth

15 paź 2025, 18:30 UTC

Acquisitions, Mergers, Takeovers

Constellation Software to Buy U.K.'s Tecvia Holding

15 paź 2025, 17:19 UTC

Acquisitions, Mergers, Takeovers

Drahi's Altice Rejects $20 Billion Joint Offer From Peers -- 2nd Update

15 paź 2025, 17:11 UTC

Acquisitions, Mergers, Takeovers

Anglo American, MMG Offer Concessions to EU Merger Watchdog in Nickel Deal Probe

15 paź 2025, 23:48 UTC

Market Talk

Gold Steady, Supported by Expectations of Ongoing Central Bank Purchases -- Market Talk

15 paź 2025, 23:38 UTC

Market Talk

Nikkei May Rise, Tracking Gains Across Most U.S. Equity Markets -- Market Talk

15 paź 2025, 22:37 UTC

Market Talk

Economic Stars Are Aligning for RBA -- Market Talk

15 paź 2025, 21:44 UTC

Earnings

Stock Rally Is Lifting Wealth Managers. How Much Is Charles Schwab Benefiting? -- Barrons.com

15 paź 2025, 20:50 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

15 paź 2025, 20:44 UTC

Acquisitions, Mergers, Takeovers

Restaurant Brands Recommends Hldrs Do Not Tender Their Shrs to the Offer >QSR.T

15 paź 2025, 20:44 UTC

Acquisitions, Mergers, Takeovers

Restaurant Brands Notified of Unsolicited Mini-Tender Offer to Buy Shrs at $28.80/Shr

15 paź 2025, 20:43 UTC

Acquisitions, Mergers, Takeovers

Restaurant Brands Notified of Unsolicited Mini-Tender Offer by NY Stk and Bond LLC to Purchase Up to 10,000 Common Shrs >QSR.T

15 paź 2025, 20:34 UTC

Earnings

Prologis Raises Outlook as Warehouse Leasing Picks Up -- WSJ

15 paź 2025, 20:31 UTC

Acquisitions, Mergers, Takeovers

RBI Recommends Hldrs Reject NYSB's "Mini-Tender Offer"

15 paź 2025, 20:17 UTC

Acquisitions, Mergers, Takeovers

GE Vernova Stock Feill With Latest Call to Sell -- Barrons.com

15 paź 2025, 19:06 UTC

Earnings

These Stocks Are Moving the Most Today: Bank of America, Morgan Stanley, ASML, AMD, Nvidia, Bunge, Progressive, Abbott, and More -- Barrons.com

15 paź 2025, 19:04 UTC

Market Talk

Oil Futures Post Back-to-Back Losses -- Market Talk

15 paź 2025, 18:46 UTC

Market Talk

U.S. Natural Gas Futures Slip Ahead of Storage Data -- Market Talk

15 paź 2025, 18:23 UTC

Earnings

This Insurer Is the One of the Worst Stocks in the S&P 500 Today. Here's Why. -- Barrons.com

15 paź 2025, 17:37 UTC

Acquisitions, Mergers, Takeovers

Constellation Software's Harris Operating Group Enters Into Agreement To Acquire TECVIA Holding GmbH >CSU.T

15 paź 2025, 17:34 UTC

Market Talk

Oil Futures Lose Ground on Trade, Oversupply Concerns -- Market Talk

15 paź 2025, 16:57 UTC

Earnings

The Nation's Biggest Banks Are Saying the Economy Is Still Strong -- WSJ

15 paź 2025, 16:51 UTC

Acquisitions, Mergers, Takeovers

EssilorLuxottica Doesn't Disclose Financial Details

15 paź 2025, 16:50 UTC

Acquisitions, Mergers, Takeovers

EssilorLuxottica: RetinAI Partners With Pharmaceutical Companies, Research Organizations

15 paź 2025, 16:49 UTC

Acquisitions, Mergers, Takeovers

EssilorLuxottica: Deal Reinforces the Group's Med-Tech Journey

15 paź 2025, 16:48 UTC

Acquisitions, Mergers, Takeovers

EssilorLuxottica: Ikerian Specializes in Artificial Intelligence, Data Management in Eyecare

15 paź 2025, 16:48 UTC

Acquisitions, Mergers, Takeovers

EssilorLuxottica: Ikerian Is a Health Technology Company, Operating Under the RetinAI Brand

15 paź 2025, 16:47 UTC

Acquisitions, Mergers, Takeovers

EssilorLuxottica Buys Ikerian

15 paź 2025, 16:34 UTC

Market Talk

AMD Data Center Agreements Will Provide Big Revenue Growth -- Market Talk

Peer Comparison

Price change

Quidel Corp Forecast

Price Target

By TipRanks

50.94% upside

12 Months Forecast

Average 39.5 USD  50.94%

High 62 USD

Low 26 USD

Based on 8 Wall Street analysts offering 12 month price targets forQuidel Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

4

Buy

3

Hold

1

Sell

Financials

$

About Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat